Moderna and Pfizer have reported excellent early results from vaccine clinical trials. Vaccines aren’t approved yet, and the rollout will take massive mobilization efforts. An independent safety and data monitoring board reported today that early results from the Moderna Phase 3 clinical trials show the company’s vaccine was 94.5% effective. That news followed equally positive …